Page last updated: 2024-11-05

thalidomide and Abdomen, Acute

thalidomide has been researched along with Abdomen, Acute in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Abdomen, Acute: A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murata, Y1
Endo, I1
Miura, A1
Ohashi, K1

Other Studies

1 other study available for thalidomide and Abdomen, Acute

ArticleYear
Spontaneous huge hematoma in the abdominal wall after lenalidomide.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:8

    Topics: Abdomen, Acute; Abdominal Wall; Antineoplastic Agents; Female; Hematoma; Humans; Lenalidomide; Middl

2011